EN
Home/Guides/Choosing a provider
Guide 7 of 9 · Stage: Do it safely

Choosing where to get a GLP-1 in the US: doctor, telehealth or clinic

Your own doctor, obesity medicine specialists, telehealth services, the makers' own pharmacies, employer programs and clinics all offer GLP-1 medicines. Here is how each route works, what you pay for, the rules they must follow, and how to check one before you hand over your details.

GLP Guidebook teamUpdated Oct 12, 202615 min read24 sourcesWritten from published sources
The short answer

Check your coverage first: your insurance, Medicare's GLP-1 Bridge or your state's Medicaid may pay. Whoever you choose, the prescriber should be licensed in your state, the pharmacy licensed with your state board, and the medicine FDA-approved, not compounded. Get the full monthly cost, including the medicine and any membership, in writing before you pay. Never buy "research use only" products.

Key facts

Who prescribes
Any prescriber licensed in your state: a doctor, and in most states a nurse practitioner or physician assistant1
Telehealth
Legal. GLP-1s aren't controlled substances, so there's no federal in-person rule2
What you pay
  • With coverage: your plan's copay, or $50 a month on Medicare's GLP-1 Bridge3
  • Without: the medicine, plus any membership or visit fees4
Under watch
The FDA warned 30 telehealth companies in March 2026 over compounded GLP-1 marketing5
On this page
  1. Why are there so many providers?
  2. Start with your coverage
  3. What kinds of provider are there?
  4. How does a telehealth service run?
  5. What should each part look like?
  6. How do they charge?
  7. What are the rules in the US?
  8. How do I check a provider?
  9. Checklist before you sign up
  10. Red flags
  11. Questions people ask
We don't name, rank or price providers. Drug and telehealth ads are everywhere in the US, and some are paid by the companies selling the medicine. We stay independent: this guide describes the kinds of provider and the rules they follow, so you can check any of them yourself. We take no money from any of them, and have no affiliate links.

Why are there so many providers?

New approvals, years of shortages, patchy insurance coverage and the makers' own cash prices all opened the door to new kinds of service.

  • Jun 2021Wegovy approved for weight management.6
  • Nov 2023Zepbound (tirzepatide) approved for weight management.7
  • 2022–2025While the medicines were in short supply, pharmacies could make compounded copies, and many online services sold them.8
  • Dec 2024–May 2025The FDA declared both shortages over, and the grace periods for compounders ended.8
  • Sep 2025 onwardThe FDA sent waves of warning letters to telehealth companies and compounders.5
  • Dec 2025–Apr 2026The Wegovy pill and Foundayo, the first GLP-1 pills for weight loss, were approved, and the makers sell them directly at self-pay prices.9,10
  • Jul 2026Medicare's temporary GLP-1 Bridge began, at $50 a month.3

Meanwhile, most employer plans still don't cover these medicines for weight loss: 19% of firms with 200 or more workers did in 2025.11 That gap is why so many people look for other routes.

Start with your coverage

Who pays shapes which provider makes sense. Check this before you sign up anywhere.

Employer or private plan
  • Call the number on your insurance card and ask: is it covered for weight, which brand is preferred, and what does prior authorization need?11
  • If it is covered, your own doctor or a specialist in your plan's network is often the simplest route.
Medicare
  • The GLP-1 Bridge covers Wegovy, the Zepbound KwikPen and Foundayo for weight at $50 a month, from July 2026 to December 2027, if you meet its criteria.3
  • Your prescriber applies through one central process. Check at Medicare.gov/glp1bridge or 1-800-MEDICARE.3
Medicaid
  • 13 states covered GLP-1s for obesity in January 2026. Ask your state program.12
No coverage
  • The makers sell directly at their own self-pay prices. Guide 6 lists them.

These are starting points, not a promise that you qualify. Guide 6 explains each route in detail, and Guide 4 helps you think through whether a GLP-1 fits you at all.

What kinds of provider are there?

Six main routes, plus sellers to avoid. They differ in who prescribes, what support you get, and who pays.

No route is automatically safer. A careful telehealth service can be better than a rushed office visit. What matters is whether the parts in the sections below are done properly.

1Your primary care doctor

The doctor, nurse practitioner or physician assistant who already knows your health, in person or by video.

Usually included
The visit, lab tests if needed, the prescription, and the prior-authorization paperwork if your plan covers it. Usually billed to your insurance.
Suits
Anyone with insurance coverage, and anyone with diabetes, heart, kidney or other conditions to manage alongside.
Watch
Some practices have long waits. Ask how often they'll check on you while the dose goes up.
2Obesity medicine specialist

A doctor or clinic that focuses on weight management. Some doctors are certified by the American Board of Obesity Medicine (ABOM).13

Usually included
A fuller assessment, a choice among medicines, and often nutrition and behavior support.
Suits
People with a higher BMI or several health problems, or who are weighing medicine against surgery.
Watch
Your plan may need a referral, and the clinic may or may not be in your network.
3Telehealth weight-loss service

An online service: a health questionnaire, a visit by video, phone or messaging, then a prescription sent to a pharmacy. Many charge a monthly membership on top of the medicine.4

Usually included
Visits and messaging with a clinician; some add lab tests, coaching, and help with insurance paperwork. Check what the membership covers.
Suits
People who can't easily see a doctor in person, or want regular check-ins online.
Watch
Whether the advertised price includes the medicine, whether it is an FDA-approved brand or a compounded version, and how long you're tied in.4,5
4The makers' own pharmacies

Eli Lilly (LillyDirect) and Novo Nordisk (NovoCare Pharmacy) sell their own brands directly at self-pay prices, with home delivery.14,15

Usually included
The medicine, delivered. You still need a prescription from a licensed prescriber of your choice.
Suits
People paying themselves who already have a prescriber.
Watch
The maker sells only its own brands, so it isn't a neutral adviser on which medicine suits you. Some self-pay prices depend on refilling within 45 days.14
5Employer or health-plan program

Some employers and plans offer weight-management benefits, including GLP-1 coverage through prior authorization.11

Suits
Anyone whose employer or plan offers one: ask HR or your plan for the rules in writing.
Watch
Coverage can depend on meeting extra conditions, and plans can change which brands they cover.16
6Weight-loss clinics and med spas

In-person clinics, sometimes in spas, that offer weight-loss injections.

Suits
Only if a licensed prescriber assesses you and the medicine is an FDA-approved brand from a licensed pharmacy.
Watch
Many sell compounded semaglutide or tirzepatide. State attorneys general have warned and acted against med spas over this.17
Not a provider: "research use only" sellers and social media. The FDA has warned sellers of GLP-1s labeled for research, and says compounded GLP-1s are not FDA-approved.8,18 Compounding pharmacies supply many online services; their products are not reviewed by the FDA for safety, effectiveness or quality.18 Guide 6 explains why.

How does a telehealth service run?

Most follow the same steps. The ones to slow down at are the checks in steps 2 and 3, and the price in step 4.

1
Online questionnaireYour health history, medicines, height and weight.
2
A visit with a licensed clinicianBy video, phone or messaging, depending on the service and your state's rules. The clinician must be licensed where you are.1
3
The prescriber decidesWithin the FDA label: a BMI of 30, or 27 with a weight-related condition. Lab tests may be ordered first.19
4
Who pays is sorted outA prior authorization to your insurer, a referral to the maker's self-pay pharmacy, or the service's own pharmacy.
5
Medicine deliveredFrom a pharmacy licensed in your state, cold where the pack needs it.20
6
Check-ins and refillsYour progress and side effects should be checked before each dose increase.

A typical pattern, not a rule. Services differ in each step.

The steps look the same from the outside. The differences are in who does each one and how carefully, which the next section covers.

What should each part look like?

Six parts, each with what good looks like and the warning sign to watch for.

1The prescriber

  • You can't find out who prescribesOr they aren't licensed in your state.1
    You get the prescriber's name and credentials, and can check the license with your state board.21

2The assessment

  • Approval in minutes, no questionsNo one asks about thyroid cancer in the family, past pancreatitis, other medicines or pregnancy plans.19
    A clinician reviews your history and medicines, checks your BMI, and says no when the medicine doesn't fit.19

3Your regular doctor and records

  • Nobody asks about your other careYour doctor may be treating things that matter, such as diabetes, with medicines that can interact.19
    The service asks for your medicine list and offers to share the prescription with your regular doctor.

4The medicine

  • A product with the service's own name on itThe FDA warned telehealth companies for selling compounded GLP-1s under their own brand names, which hides who made them, and for implying they are the same as approved drugs.5
    An FDA-approved brand (such as Wegovy, Zepbound or Foundayo) in its sealed pack, from a licensed pharmacy. If anything seems wrong, don't use it and report it to MedWatch.22

5Diet, coaching and the app

  • The medicine sold as the whole answerThe FDA labels approve these medicines alongside a reduced-calorie diet and more physical activity, not instead of them.19
    Advice on eating enough protein and doing strength exercise to protect muscle (see Guide 8). Questions about side effects or your dose go to a clinician, not only an app or a coach.

6Reviews and stopping

  • Doses keep going up with no reviewRefills sent on a timer, with no one asking how you are.
    Regular reviews of your weight and side effects, and a plan for stopping (see Guide 9).

How do they charge?

With coverage, you pay your plan's share. Without it, the medicine is the biggest part of the bill, and many services add a membership on top.

We don't publish any provider's prices. They change often and depend on the plan. Below is how the fees are built.

Insurance that covers itYour plan's copay or coinsurance, after prior authorization. A maker's savings card may lower it.11,14
Medicare GLP-1 Bridge$50 a month for the medicine, if you qualify, until December 31, 2027.3
Paying for the medicine yourselfThe makers' self-pay prices: $149 to $449 a month, depending on brand and dose, checked Oct 12, 2026. See them all.14,15
Membership or visit feesMany telehealth services charge a monthly membership for visits and support. It may not include the medicine.4
Ask one question before you pay: "What will I pay each month, all in, once I'm on my full dose?" In 2025 the FTC acted against a telehealth weight-loss company whose advertised monthly price left out the medicine, lab tests and required visits, and hid long commitments.4 A starting-dose price also looks cheaper than it will be: Zepbound's self-pay price is $299 at the starting dose and $449 at higher doses.14 Then put your numbers into the GLP-1 cost calculator.

Budget in years, not months: Guide 9 explains what happens to your weight when you stop. A long prepaid plan isn't automatically good value if you may need to stop or change medicine early. Lilly says HSA or FSA eligibility for its medicines may vary by plan; check with your benefits administrator.15

What are the rules in the US?

Every provider, online or not, works under federal rules on medicines and advertising, and state rules on licensing.

All GLP-1 medicines need a prescription.19 They are not controlled substances, so the federal rule requiring an in-person visit before prescribing some medicines online doesn't apply to them.2

Licensing (states)
  • Prescribers need a license in the state where you are when you get care. Interstate compacts make extra licenses faster, but don't remove the need.1
  • Pharmacies are licensed by state boards of pharmacy.20
  • Some states have their own rules on telehealth prescribing; ask the service how it follows yours.
Who the label is for
  • The weight-loss labels cover adults with a BMI of 30 or more, or 27 to under 30 with at least one weight-related condition, and the same numbers apply to everyone.19
  • Ozempic and Mounjaro are approved for type 2 diabetes, not weight loss.19
Compounded drugs (FDA)
  • Compounded GLP-1s are not FDA-approved, and since the shortages ended, pharmacies may not regularly make copies of approved drugs.8,18
  • Sellers may not claim they're generics, the same as approved drugs, or clinically proven.5,23
Advertising (FDA and FTC)
  • Drug ads to the public are legal in the US. The FDA oversees ads by drug makers, and in September 2025 launched a crackdown on misleading ones.24
  • The FTC acts against deceptive pricing, reviews and testimonials, including by telehealth services.4

How do I check a provider?

Every prescriber and pharmacy in the US is licensed by a state board. Look them up before you share your details.

PharmaciesCheck the license with your state board of pharmacy; the FDA's BeSafeRx locator links to each board's database. A safe online pharmacy requires a prescription, has a US address and phone number, and a licensed pharmacist.20
Doctors and physician assistantsSearch your state medical board, or the free DocInfo.org search from the Federation of State Medical Boards, which shows license history and board actions.21
Nurse practitionersSearch your state board of nursing.
Obesity medicine certificationThe American Board of Obesity Medicine lets you verify a doctor's certification.13
Something went wrong?Report side effects or a suspect product to the FDA's MedWatch (1-800-FDA-1088).22 Report misleading ads or billing to the FTC at ReportFraud.ftc.gov, and concerns about a prescriber or pharmacy to its state board.

Checklist before you sign up

Tick as you go. Any box you can't tick is a question to ask before you pay.

Before you pay

At the visit

Once you're in

For questions to ask about the medicine itself, use Guide 6's question list or the doctor-visit tool.

Red flags

Any one of these is a reason to stop and look elsewhere.

  • "No prescription needed", or sold on social mediaSafe pharmacies always require a prescription.20
    Supplies only after an assessment and a prescription.
  • "Research peptides", "same as Ozempic" or "generic Wegovy"There is no generic semaglutide or tirzepatide in the US, and the FDA has warned sellers over these claims.5,18,23
    Supplies only FDA-approved medicines, in their own packs.
  • A price that leaves out the medicineThe FTC acted against exactly this.4
    States the all-in monthly cost and the cancellation terms before you pay.
  • Sold for looks, or for a few pounds before a vacationThe labels cover obesity, or overweight with a weight-related condition.19
    Prescribes within the label, and says no when you don't meet it.19
  • Promises of how much you'll lose, or glowing before-and-after photosThe FTC's case included fake reviews and testimonials.4 Trial results are averages: some people lose much more, some very little.
    Quotes trial results with the trial's name, length and dose, and says results vary. See Guide 2.

Already signed up and worried? Don't stop your medicine without talking to a doctor first. Report side effects or a suspect product to MedWatch,22 and concerns about a prescriber or pharmacy to its state board.

Questions people ask

Before you sign up

Should I go through my own doctor or a telehealth service?

Either can be safe. If your insurance covers GLP-1s, your own doctor or an in-network specialist is often the simplest route, because prior authorization goes through them.11 Whatever you choose, the prescriber should be licensed in your state and the medicine FDA-approved.1,18

Is it legal to get a GLP-1 through telehealth?

Yes, from a prescriber licensed in the state where you are.1 GLP-1s are not controlled substances, so there's no federal rule requiring an in-person visit first.2

Is a telehealth membership worth it?

It depends on what it includes. Ask whether the price covers the medicine, labs and visits, and how to cancel. The FTC has acted against a service whose advertised price didn't include the medicine.4

Can I buy straight from the maker?

Lilly and Novo Nordisk sell their own brands directly at self-pay prices. You still need a prescription from a licensed prescriber.14,15

Once you're in

My service switched me to a compounded version. Is that OK?

Compounded GLP-1s are not FDA-approved or generics.18 Ask why, and talk to your prescriber about an FDA-approved brand. Don't change your dose on your own.

What if I'm told a GLP-1 isn't right for me?

That's the check working. Ask what to do instead; Guide 3 covers the other options.

Before you move on

  • Check your coverage first.
  • Check the prescriber's and pharmacy's licenses with your state boards.
  • Insist on an FDA-approved brand, not a compounded version.
  • Get the all-in monthly cost at your full dose, in writing.
Getting a prescription in the USShould I consider a GLP-1?Telehealth memberships
Was this guide easy to understand?

Sources

  1. American Medical Association. How state licensing has evolved to meet telehealth's challenges (physicians "licensed in the state where their patients are receiving their care"; Interstate Medical Licensure Compact). October 12, 2023. ama-assn.org
  2. Drug Enforcement Administration, Diversion Control Division. Controlled substances, alphabetical order (semaglutide, tirzepatide, liraglutide and dulaglutide not listed). List dated August 27, 2026. deadiversion.usdoj.gov
  3. Centers for Medicare & Medicaid Services. Medicare GLP-1 Bridge: information for prescribers (July 1, 2026, to December 31, 2027; $50 copay; covered products; criteria; Medicare.gov/glp1bridge, 1-800-MEDICARE). Product No. 12235, June 2026. cms.gov
  4. Alston & Bird. FTC deceptive-practices settlement with a telehealth company: the FTC's final order of December 3, 2025, against NextMed (Southern Health Solutions), whose monthly membership prices did not include the GLP-1 drugs, lab work or required consultations; hidden terms and fake reviews and testimonials. December 11, 2025. Law-firm analysis. alston.com
  5. FDA. FDA warns 30 telehealth companies against illegal marketing of compounded GLP-1s (claims implying sameness with FDA-approved products; products branded with the telehealth firm's name). March 3, 2026. fda.gov
  6. FDA. FDA approves new drug treatment for chronic weight management, first since 2014 (Wegovy). June 4, 2021. fda.gov
  7. FDA. FDA approves new medication for chronic weight management (Zepbound). November 8, 2023. fda.gov
  8. FDA. FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize (shortages resolved; 503A and 503B grace periods ended February–May 2025). Content current as of April 1, 2026. fda.gov
  9. Novo Nordisk. Wegovy pill approved in the US as first oral GLP-1 for weight management. December 22, 2025. Company announcement. placera.se
  10. Eli Lilly. FDA approves Lilly's Foundayo (orforglipron) (available via LillyDirect, then US retail pharmacies and telehealth providers). April 1, 2026. Company announcement. investor.lilly.com
  11. KFF. 2025 Employer Health Benefits Survey (19% of firms with 200 or more workers cover GLP-1s primarily for weight loss; coverage typically subject to prior authorization). kff.org
  12. KFF. Medicaid coverage of and spending on GLP-1s (13 states as of January 2026). January 16, 2026. kff.org
  13. American Board of Obesity Medicine. About certification ("Certification as an ABOM diplomate signifies specialized knowledge in the practice of obesity medicine"); Find a physician / verify credentials. Checked October 12, 2026. abom.org
  14. Eli Lilly. Zepbound coverage and savings (LillyDirect self-pay: 2.5 mg $299, 5 mg $399, 7.5–15 mg $449 with refills within 45 days; savings card for commercial coverage). Checked October 12, 2026. zepbound.lilly.com
  15. Eli Lilly. Foundayo coverage and savings (self-pay from $149 a month; "FSA/HSA eligibility may vary by plan"); and Novo Nordisk, NovoCare Wegovy self-pay offer (from $149 a month for the pill). Checked October 12, 2026. foundayo.lilly.com · novocare.com
  16. Medicare.gov. Drug plan rules (formularies can change; prior authorization; step therapy). Checked October 12, 2026. medicare.gov
  17. Connecticut Office of the Attorney General. Attorney General Tong announces new developments in crackdown on bootleg GLP-1 weight-loss drugs (letters and cease-and-desist demands to medical spas and weight-loss clinics advertising compounded GLP-1s). 2025. portal.ct.gov
  18. FDA. FDA's concerns with unapproved GLP-1 drugs used for weight loss (compounded drugs not FDA-approved and not reviewed for safety, effectiveness or quality; "research use only" products). Content current as of October 1, 2026. fda.gov
  19. Novo Nordisk. Wegovy US prescribing information, revised June 2026; Eli Lilly, Zepbound US prescribing information, revised August 2026 (indications, BMI criteria, contraindications, warnings). Wegovy · Zepbound
  20. FDA. How to buy medicines safely from an online pharmacy (signs of a safe pharmacy; check the license with the state board of pharmacy using BeSafeRx). Content current as of January 2, 2025. fda.gov
  21. Federation of State Medical Boards. DocInfo tool provides consumers physician licensure and disciplinary data (free). August 19, 2015. newswise.com
  22. FDA. MedWatch: the FDA safety information and adverse event reporting program (1-800-FDA-1088). Content current as of October 9, 2026. fda.gov
  23. FDA. FDA intends to take action against non-FDA-approved GLP-1 drugs (no claims of being "generic versions or the same as drugs approved by FDA", or "clinically proven"). February 6, 2026. fda.gov
  24. FDA. FDA launches crackdown on deceptive drug advertising. September 9, 2025. fda.gov

Last checked Oct 12, 2026 · Next review due Jan 2027 · Report an error

How this guide was made. Written by the GLP Guidebook team from the sources above: FDA, FTC, CMS and DEA material, state licensing bodies, KFF research and the makers' published prices. We don't name, rank or price any pharmacy, clinic or telehealth service; the makers' own pharmacies are described as facts, not recommendations. It's general information, not medical advice. Talk to your doctor before starting, stopping or changing any medicine. In an emergency, call 911. How we write